Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Gastroenteritis Testing Market Revenue Outlook: What CAGR Lies Ahead Through 2030?#_x000D_
The gastroenteritis testing market has shown robust growth in recent years. It is projected to increase from $4.18 billion in 2025 to $4.44 billion in 2026, at a compound annual growth rate (CAGR) of 6.1%. The expansion observed in the past can be attributed to several factors, including the continued dependence on conventional immunoassay and culture-based techniques, the limited accessibility of advanced molecular diagnostics, a rise in the prevalence of gastrointestinal infections, improvements in hospital and clinic diagnostic capabilities, and the growing number of research institutes conducting studies on infectious diseases._x000D_
_x000D_
The gastroenteritis testing market is poised for significant expansion over the next few years. It is forecast to attain a value of $5.55 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.8%. This growth throughout the projected period is attributable to advancements in molecular diagnostic technologies, an increasing need for rapid point-of-care testing solutions, augmented funding for infectious disease research, wider adoption of integrated laboratory information systems, and the extension of gastroenteritis testing services into emerging markets. Prominent developments anticipated during this forecast period include an escalating demand for swift and accurate gastroenteritis diagnostics, a growing preference for molecular diagnostic testing methodologies, the expansion of testing panels to cover viral, bacterial, and parasitic infections, an increase in point-of-care and hospital-based diagnostic services, and a more concentrated focus on epidemiological surveillance and outbreak control._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Gastroenteritis Testing Market Growth Drivers: What’s Behind The Acceleration?#_x000D_
The escalating occurrence of bacterial infections is anticipated to stimulate the future growth of the gastroenteritis testing market. The rise in these infections is driven by factors such as enhanced antibiotic resistance, increased population density, and greater global travel, which together facilitate the spread of resistant bacteria. Gastroenteritis testing is crucial for bacterial infections to accurately identify the specific pathogen causing symptoms like diarrhea and vomiting, which then guides appropriate treatment and helps prevent further spread of infection. For instance, in 2024, GOV.UK, a UK-based organization, reported that cases of serious bacteraemia caused by antibiotic-resistant bacteria had increased by 9.3% since 2023, rising from 18,740 cases in 2023 to 20,484 cases in 2024. Consequently, the increasing incidence of bacterial infections is a key factor propelling the expansion of the gastroenteritis testing market._x000D_
_x000D_
#Gastroenteritis Testing Market Segment Analysis: What Are The Core Market Categories?#_x000D_
The gastroenteritis testing market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Viral Gastrointestinal Infections, Bacterial Gastrointestinal Infections, Parasitic Gastrointestinal Infections_x000D_
2) By Disease Strains: Bacterial Strains, Viral Strains, Parasitic Strains_x000D_
3) By Testing Methods: Immunoassay Testing, Conventional Testing, Molecular Diagnostic Testing_x000D_
4) By End-User: Hospitals, Clinics Or Medical Centers, Research Institutes, Diagnostic Laboratories_x000D_
_x000D_
Subsegments:_x000D_
1) By Viral Gastrointestinal Infections: Norovirus, Rotavirus, Astrovirus, Adenovirus, Sapovirus _x000D_
2) By Bacterial Gastrointestinal Infections: Escherichia coli (E. coli), Salmonella, Campylobacter, Shigella, Clostridium perfringens _x000D_
3) By Parasitic Gastrointestinal Infections: Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella, Strongyloides stercoralis_x000D_
_x000D_
#Gastroenteritis Testing Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_
Leading companies in the gastroenteritis testing market are developing innovative products, such as molecular gastrointestinal tests, to deliver high sensitivity and specificity. A molecular gastrointestinal test functions as a diagnostic technique that utilizes molecular methods, like polymerase chain reaction (PCR), to identify and detect specific genetic material from pathogens or organisms present in gastrointestinal samples. For example, in June 2024, QIAGEN N.V., a Germany-based provider of sample and assay technologies, introduced the QIAstat-Dx Gastrointestinal Panel 2. This panel is distinguished by its capability to swiftly and comprehensively detect up to 16 clinically relevant bacterial, viral, and parasitic pathogens responsible for most gastrointestinal infections. It leverages real-time polymerase chain reaction (PCR) technology to amplify multiple genetic targets in a single reaction, marking a substantial enhancement over traditional microbiological methods that typically demand 24 hours to 10 days for sample incubation._x000D_
_x000D_
#Gastroenteritis Testing Market Leading Players And Competitive Positioning#_x000D_
Major companies operating in the gastroenteritis testing market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Abbott Diagnostics, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Eurofins Scientific SE, Hologic Inc., Becton Dickinson and Company, bioMérieux SA, Quest Diagnostics Incorporated, DiaSorin S.p.A., Bio-Rad Laboratories Inc., Randox Laboratories Ltd., ARUP Laboratories, Meridian Bioscience Inc., MedGenome, Trinity Biotech plc, Savyon Diagnostics Ltd., Coris BioConcept, Aster Clinical Research & Diagnostic Centre Pvt. Ltd., Alimetrix Inc., Luminex Corporation _x000D_
_x000D_
#View The Full Gastroenteritis Testing Market Report:#_x000D_
_x000D_
#Gastroenteritis Testing Market Regional Split: Which Areas Are Fueling Growth?#_x000D_
North America was the largest region in the gastroenteritis testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroenteritis testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
